4-Tert-Butylcyclohexanecarbaldehyde
Common Name: |
4-Tert-Butylcyclohexanecarbaldehyde |
IUPAC Name: |
4-tert-butylcyclohexane-1-carbaldehyde |
Molecular Formula: |
C11H20O |
SMILES: |
CC(C)(C)C1CCC(CC1)C=O |
Inchi: |
1S/C11H20O/c1-11(2,3)10-6-4-9(8-12)5-7-10/h8-10H,4-7H2,1-3H3 |
Inchi Key: |
MXGRYXNVQNESIN-UHFFFAOYSA-N |
Cas No: |
20691-52-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
168.28 |
Mass (g/mol) |
168.151 |
Molar Refractivity |
52.82 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
1 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
221.00 to 222.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.1 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.91 |
LogP |
3.038 |
iLOGP |
2.40 |
XLOGP3 |
3.25 |
WLOGP |
3.04 |
MLOGP |
2.59 |
ESOL Log S |
-2.80 |
ESOL Solubility (mg/ml) |
0.267 |
ESOL Solubility (mol/l) |
0.002 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.28 |
Ali Solubility (mg/ml) |
0.09 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.24 |
Silicos-IT Solubility (mg/ml) |
0.97 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.02 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.516 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.155 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |